Effects of empagliflozin, diet, or both on physical activity and sedentary behaviour in people with type 2 diabetes: analyses from the SEESAW trial [Abstract]
conference contribution
posted on 2020-12-10, 16:33 authored by Jack Sargeant, James KingJames King, Emma Baldry, Danielle Bodicoat, Charlotte Edwardson, Kamlesh Khunti, David StenselDavid Stensel, David Webb, John Wilding, Tom Yates, Melanie DaviesNo description supplied
History
School
- Sport, Exercise and Health Sciences
Published in
DiabetologiaVolume
63Issue
Suppl 1Pages
S270 - S271Source
56th Annual Meeting of the European Association for the Study of Diabetes (EASD 2020)Publisher
SpringerVersion
- AM (Accepted Manuscript)
Rights holder
© Springer-Verlag GmbH Germany, part of Springer NaturePublisher statement
This is a post-peer-review, pre-copyedit version of an article published in Diabetologia. The final authenticated version is available online at: https://doi.org/10.1007/s00125-020-05221-5.Acceptance date
2020-05-27Publication date
2020-08-25Copyright date
2020ISSN
0012-186XeISSN
1432-0428Publisher version
Language
- en
Location
ViennaEvent dates
21st September 2020 - 25th September 2020Depositor
Dr James King Deposit date: 27 May 2020Article number
564Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC